Health

Challenges and Prospects, Upcoming Webinar Hosted by Xtalks

Leave a comment


Artificial intelligence (AI) has been introduced as a promising tool to handle the abundant data and extract the information efficiently.


TORONTO (PRWEB)

Target identification has been an important challenge in developing therapeutics, significantly affecting its success rate. Thanks to the endeavour to address this issue and the recent drastic advance in technologies, an enormous amount of multilayered information surrounding the related biological entities has been accumulated. Artificial intelligence (AI) has been introduced as a promising tool to handle the abundant data and extract the information efficiently. AI is contributing to this area in many aspects based on diverse data sources.

Standigm has been focusing on diverse AI/machine learning (ML) approaches to identify novel targets. This has resulted in the construction of a highly flexible and modularised platform to streamline the target research processes.

This proprietary platform for target identification comprises four different approaches: A deep learning model based on a knowledge graph; A Natural Learning Processing (NLP) engine extracting information from scientific literature; A random-walk model based on a modified protein-protein interaction (PPI) network and omics data; And a genome-scale metabolic model incorporating genetic information.

This system enables the users to get insights of novel drug targets and is currently contributing to initiate the company’s internal pipelines with minimised human intervention. Simultaneously, Standigm is actively evaluating the platform through diverse collaborations with pharmaceutical companies, biopharma companies, universities and research institutes.

Register for this webinar to learn about the introduction of AI-based approaches for target identification. Attendees will explore the potential opportunities and prospects of target identification processes with AI, including the importance of collaborative efforts.

Join Dr. Heejung Koo, Vice President of Strategic Alliances, Standigm UK, for the live webinar on Tuesday, June 7, 2022, at 3pm EDT (12pm PDT).

For more information, or to register for this event, visit Facilitating Target Identification Processes with AI: Challenges and Prospects.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Leave a Reply